The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Finerenone (Firialta) is indicated to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
